This post investigates what has happened to Samsung Biologics with the CMO deal rumor yesterday and discusses Samsung C&T synthetic subsidiary stub trades as a result of this market noise.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.